Accelerate and Improve Scientific Outcomes with TetraScience

TetraScience is the R&D Data Cloud company with a mission to transform life sciences R&D, accelerate discovery, and improve and extend human life. While the company was founded in 2014, the company began its R&D Data Cloud journey in 2019 with the origin of the Tetra Data Platform (TDP).

The Tetra R&D Data Cloud provides life sciences companies with the flexibility, scalability, and data-centric capabilities to enable easy access to centralized, harmonized, and actionable scientific data and is actively deployed across enterprise pharma and biotech organizations. As an open platform, TetraScience has built the largest integration network of lab instruments, informatics applications, CRO/CDMOs, analytics, and data science partners, creating seamless interoperability and an innovation feedback loop that will drive the future of life sciences R&D.

To meet the unique demands of the world’s most important research labs, TetraScience has developed three unique and integrated capabilities – the Tetra Data Platform, Tetra Partner Network, and Tetra Solutions Team composed of scientists, data scientists, and cloud experts – to deliver the world’s first and only open R&D industry data cloud capable of ingesting and engineering data from any lab source.

The TetraScience team combines a deep understanding of life sciences R&D with cloud-native mindsets and data science expertise. Backed by Insight Partners, Alkeon Capital Management, Underscore, and Impetus Ventures, TetraScience currently counts over 100 leading pharmaceutical and biotech companies as customers.

Meeting the Growing Needs of BioTech

The biotech industry broke many of its own records in 2021. A total of 176 biotech companies priced IPOs in 2021, the busiest year by deal count since 2000, according to IPO research firm, Renaissance Capital, and IPOscoop.com.  Venture capital funding for biotech companies hit record highs nationally in 2022, exceeding $30 billion for the first time in the 12-month period ending September 2021. In Massachusetts alone, 2021 shattered records — with biotech garnering $13.66 billion in venture capital funding; surpassing the sum of statewide venture capital funding for biotech in 2019 and 2020, and marking an increase of 70%, year over year.

The company announced the expansion offerings to meet the needs of the fast-growing biotech segment. "Biotech companies need and expect scientific discovery to occur at the speed of cloud computing," says Chad Garrett, Chief Revenue Officer with TetraScience. "For this, their cloud-native tech stacks must be purpose-built around their workflows and the use cases they serve. The Tetra R&D Data Cloud has proven to have ideal product-market fit for these fast-moving organizations."

Faced with scientific data coming from hundreds of different instruments and sources in different proprietary formats, biotech organizations typically want to start and scale their operations by having all of their scientific data harmonized, centralized, and stored in the cloud. The Tetra R&D Data cloud, which includes productized integrations from the Tetra Partner Network, uniquely solves these problems by seamlessly collecting and archiving scientific data, validating it, harmonizing it, and preparing it for deeper analysis.

About the Leader

Patrick Grady, Chairman & CEO

Patrick helped pioneer several of the core technologies - including web services, service oriented architectures (SOA), and software-as-a-service (SaaS) - which now undergird the $100B B2B cloud market. He also played a pivotal role in commercializing virtual assistant/AI technology which is now ubiquitous in consumer applications such as Siri, Alexa, and Google Assistant. A highly-regarded visionary and CEO in cloud platforms and apps, business and data networks, B2B commerce, and FinTech, he’s been recognized as one of the leading CEOs and innovators in the B2B market on numerous occasions. Patrick was also a recipient of the 2006 Fast Company award, given to the top 50 people in the world to “change the way we live and work”, for his pioneering efforts in virtual agent / AI technology, joining Bill Gates and Bill Clinton among others that year.

Patrick was the founder and CEO of Rearden Commerce, the first enterprise SaaS company and one of the most innovative and fastest growing companies of the early Cloud era. By 2011, Rearden was worth $1.5B, making it the 6th most valuable privately-held tech company in the world at the time. Rearden’s high-water mark of $1.5B was artificially capped by strategic investors who committed a number of egregious governance and commercial contract breaches which forced the company to sub-optimize and exit early. Unimpeded by these actions, given its recurring revenue and competitive moats, Rearden today would be worth well in excess of $40B. These breaches also deeply impaired one of Silicon Valley's greatest cultures, leaving Patrick more passionate than ever about building and preserving inspirational, empowering, and impactful cultures, and ensuring best-in-class governance.

Patrick serves as Executive Chairman at Clearbit, the marketing data engine for all customer interactions. Clearbit is funded by Zetta, Bedrock, First Round Capital, and Battery Ventures, among others.

"The Tetra R&D Data Cloud provides life sciences companies with the flexibility, scalability, and data-centric capabilities to enable easy access to centralized, harmonized, and actionable scientific data and is actively deployed across enterprise pharma and biotech organizations."

"The TetraScience team combines a deep understanding of life sciences R&D with cloud-native mindsets and data science expertise."